About Laurie Stelzer

Laurie joined Mirati in 2022 as Chief Financial Officer (CFO), bringing with her 25 years of experience in biopharmaceutical management. In her role at Mirati, Laurie is responsible for leading Finance and Accounting, Corporate Affairs, Facilities and Information Technology. Prior to Mirati, Laurie served as the Executive Vice President and CFO of Arena Pharmaceuticals (acquired by Pfizer). Prior to joining Arena, she was the CFO at Halozyme Therapeutics.

Earlier in her career, Laurie held senior management roles at Shire Plc, including Senior Vice President of Finance, Division CFO for the Regenerative Medicine Division, and Head of Investor Relations. Previously she held positions of increasing responsibility during her fifteen-year career at Amgen, Inc., spanning the areas of finance and international/emerging markets.

Laurie currently serves on the board of directors for Surface Oncology and PMV Pharmaceuticals, Inc. She received her B.S. in Accounting from Arizona State University, and her M.B.A. from the Anderson School of Management at the University of California, Los Angeles.